Psilocybin & migraine: First of its kind trial reports promising results

Posted on December 01 2020

Psilocybin & migraine: First of its kind trial reports promising results

A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin found in so called 'Magic Mushrooms' can reduce migraine frequency by 50 percent for a least two weeks.

The preliminary trial was small, with follow-up work necessary to validate the results, but the promising findings suggest great potential for psychedelics to treat migraines and cluster headaches.

Unusually, the effect doesn't seem to be correlated with the intensity of subjective effects, which suggests sub-hallucinogenic microdoses may also be effective.

You can read more about psychedelics as analgesics on the Beckley Foundation website:
https://www.beckleyfoundation.org/pain/

Sources: The Beckley Foundation, New Atlas.

1 comment

  • Shaman Pete: December 03, 2020

    This worked for me, for the period I was microdosing mushrooms I never got migraines. Must try it again as they have come back since I stopped and I have been unable to sort more. Would be ideal if they would at least legalise fresh mushrooms on prescription for us migraine sufferers, it really works to improve our quality of life without the awful hangover traditional meds leave us with.

Leave a comment

All blog comments are checked prior to publishing

Recent Posts